News
News releases on March 30, 2016, page 30
Every news release public companies put out on March 30, 2016 (UTC): 6,578 news releases, newest first. Open any release to read it.
Prana Provides Clinical Trials Update
Alterity Therapeutics Ltd. · Mar 30, 2016
Prana Doses First Patient in the IMAGINE Phase II Trial
Alterity Therapeutics Ltd. · Mar 30, 2016
Prana Comments on Neurology Publication Huntington Data
Alterity Therapeutics Ltd. · Mar 30, 2016
First Patient Enrolled in Phase II Huntington Disease Trial
Alterity Therapeutics Ltd. · Mar 30, 2016
Appendix 4E - Preliminary Financial Report
Alterity Therapeutics Ltd. · Mar 30, 2016
Appendix 4C - Quarterly report
Alterity Therapeutics Ltd. · Mar 30, 2016
Pranas PBT434 shows potential as treatment in PD
Alterity Therapeutics Ltd. · Mar 30, 2016
Pranas PBT434 Inhibits PD Protein & Brain Cell Death
Alterity Therapeutics Ltd. · Mar 30, 2016
Pranas PBT2 Reduces Tau Related Cognitive Impairment
Alterity Therapeutics Ltd. · Mar 30, 2016
Prana Provides Huntington Disease Trial Update
Alterity Therapeutics Ltd. · Mar 30, 2016
Prana Provides Clinical Trials Safety and Progress Update
Alterity Therapeutics Ltd. · Mar 30, 2016
Prana Doses 1st Patient in PBT2 Alzheimers Extension Study
Alterity Therapeutics Ltd. · Mar 30, 2016
Prana details PBT2 data on reduced Tau Cognitive Impairment
Alterity Therapeutics Ltd. · Mar 30, 2016
Prana Completes Recruitment in Huntington Trial
Alterity Therapeutics Ltd. · Mar 30, 2016
Prana Completes Recruitment in Alzheimers Trial
Alterity Therapeutics Ltd. · Mar 30, 2016
Prana Completes Phase 2 Huntington Disease Trial with PBT2
Alterity Therapeutics Ltd. · Mar 30, 2016
Prana Announces Successful A$7 milion Capital Raising
Alterity Therapeutics Ltd. · Mar 30, 2016
Prana announces $5.8 million R&D refund
Alterity Therapeutics Ltd. · Mar 30, 2016
New York Academy of Sciences Symposium Discusses PBT2
Alterity Therapeutics Ltd. · Mar 30, 2016
New benchmark test to assess HD patients in clincial trials
Alterity Therapeutics Ltd. · Mar 30, 2016
Prana Updates Progress on PBT2 Trials
Alterity Therapeutics Ltd. · Mar 30, 2016
Pranas PBT2 Reverses Memory Loss in Normal Aging
Alterity Therapeutics Ltd. · Mar 30, 2016
Prana Provides Update on Clinical Trials for Alzheimers
Alterity Therapeutics Ltd. · Mar 30, 2016
Prana completes PBT2 dosing in IMAGINE AD Trial
Alterity Therapeutics Ltd. · Mar 30, 2016
Parkinsons UK Awards GBP150,000 to Study Pranas PBT434
Alterity Therapeutics Ltd. · Mar 30, 2016
Appendix 4E Preliminary Final Report and Statutory Accounts
Alterity Therapeutics Ltd. · Mar 30, 2016
Prana Alzheimers disease Development Program update
Alterity Therapeutics Ltd. · Mar 30, 2016
MFC Establishes Dedicated Nickel Development Vehicle
Alpha HPA Limited · Mar 30, 2016
Appendix 4D and Half Year Accounts 31 Dec 09
Pacific Current Group Ltd · Mar 30, 2016
Resignation of Managing Director
Pacific Current Group Ltd · Mar 30, 2016
FUM as at 31 Dec 2010
Pacific Current Group Ltd · Mar 30, 2016
FUM as at 30 September 2011
Pacific Current Group Ltd · Mar 30, 2016
David Cooper ceases interim executive role
Pacific Current Group Ltd · Mar 30, 2016
Appointment of New CEO
Pacific Current Group Ltd · Mar 30, 2016
Appendix 4E and Financial Statements as at 30 June 2010
Pacific Current Group Ltd · Mar 30, 2016
App 4E and Financial Statements as at 30 June 2011
Pacific Current Group Ltd · Mar 30, 2016
App 4D and Half Year Accounts - 31 Dec 10
Pacific Current Group Ltd · Mar 30, 2016
Six month Results - restructuring costs
Pacific Current Group Ltd · Mar 30, 2016
FUM as at 31 March 2012
Pacific Current Group Ltd · Mar 30, 2016
FUM as at 31 December 2011
Pacific Current Group Ltd · Mar 30, 2016
Full Year Profit Guidance - 30 June 2012
Pacific Current Group Ltd · Mar 30, 2016
App 4D and Half year accounts - 31 Dec 11
Pacific Current Group Ltd · Mar 30, 2016
Completion of Share Sale Agreement and Drilling Commenced
Neurizon Therapeutics Limited · Mar 30, 2016
Placement & Offer to Purchase Pela Resources
Neurizon Therapeutics Limited · Mar 30, 2016
PharmAust to acquire rights to 3 oncology product platforms
Neurizon Therapeutics Limited · Mar 30, 2016
Clarification on Record Date for SPP
Neurizon Therapeutics Limited · Mar 30, 2016
Appendix 4D / Half Year Financial Report
Neurizon Therapeutics Limited · Mar 30, 2016
Appendix 4D and Financial Report Dec 2012
Neurizon Therapeutics Limited · Mar 30, 2016
PharmAust Fully Executes Share Sale Agreement With Pitney
Neurizon Therapeutics Limited · Mar 30, 2016
Key Licence Provided by NewSouth Innovations
Neurizon Therapeutics Limited · Mar 30, 2016
Important Discovery in Cancer Therapy
Neurizon Therapeutics Limited · Mar 30, 2016
Clinical Study with PPL-1 Initiated following Approval
Neurizon Therapeutics Limited · Mar 30, 2016
Appendix 4C - Quarterly
Neurizon Therapeutics Limited · Mar 30, 2016
Appendix 4C
Neurizon Therapeutics Limited · Mar 30, 2016
Human Cancer Trial Advancing To Second Patient
Neurizon Therapeutics Limited · Mar 30, 2016
Clinical Trial in Dogs is now open for accrual
Neurizon Therapeutics Limited · Mar 30, 2016
Appendix 4C Quarterly & Company Update
Neurizon Therapeutics Limited · Mar 30, 2016
Prospectus Lodged
Ionic Rare Earths Limited · Mar 30, 2016
Timon Project Update
Ionic Rare Earths Limited · Mar 30, 2016
Timon Drilling Update
Ionic Rare Earths Limited · Mar 30, 2016
OVL: Oro Verde Signs Binding Agreement
Ionic Rare Earths Limited · Mar 30, 2016
Entitlement Issue Prospectus
Ionic Rare Earths Limited · Mar 30, 2016
Favourable Amendment to Terms of Convertible Notes
Orion Minerals Limited · Mar 30, 2016
Drilling Intersects Reef Structures at Happy Go Lucky
Orion Minerals Limited · Mar 30, 2016
Drilling Suggests Significant System of Gold Mineralisation
Orion Minerals Limited · Mar 30, 2016
$1.5 million Loan Facility
Orion Minerals Limited · Mar 30, 2016
Continued Encouragement at Toombon - New Dawn
Orion Minerals Limited · Mar 30, 2016
Breakthrough Understanding of Structural Controls at Cohen`s
Orion Minerals Limited · Mar 30, 2016
2011 Dilling Program to Commence Mid August
Orion Minerals Limited · Mar 30, 2016
Orion signs HoA to acquire key tenements in Fraser Range
Orion Minerals Limited · Mar 30, 2016
New Queensland EPM Application and Update
Orion Minerals Limited · Mar 30, 2016
Appointment of Managing Director and CEO
Orion Minerals Limited · Mar 30, 2016
Strong bedrock conductor detected - Fraser Range tenements
Orion Minerals Limited · Mar 30, 2016
Compelling nickel-copper targets defined at Fraser Range
Orion Minerals Limited · Mar 30, 2016
Phase 1 Drilling Completed - Peninsula Nickel-Copper Project
Orion Minerals Limited · Mar 30, 2016
Orion identifies 19 more promising anomalies in Fraser Range
Orion Minerals Limited · Mar 30, 2016
Orion Gears Up For Next Key Phase of Drilling - Fraser Range
Orion Minerals Limited · Mar 30, 2016
New VTEM survey confirms potential of CE Prospect
Orion Minerals Limited · Mar 30, 2016
Key tenements granted at Connors Arc epithermal gold project
Orion Minerals Limited · Mar 30, 2016
Drilling Confirms PGM-Rich Polymetallic Opportunity
Orion Minerals Limited · Mar 30, 2016
Pennor Mafic Intrusive Confirmed as Highly Prospective
Orion Minerals Limited · Mar 30, 2016
ORN to Raise up to $2.4m in Underwritten Entitlements Issue
Orion Minerals Limited · Mar 30, 2016
ORN: Option Agreement - Walhalla Project
Orion Minerals Limited · Mar 30, 2016
Orion initiates immediate drilling program at Fraser Range
Orion Minerals Limited · Mar 30, 2016
Loan Facilities Variation
Orion Minerals Limited · Mar 30, 2016
Exploration Update - Fraser Range Nickel-Copper Project, WA
Orion Minerals Limited · Mar 30, 2016
Drilling Program Set to Commence at Fraser Range
Orion Minerals Limited · Mar 30, 2016
Drilling Confirms Significant Nickel Potential at Pennor
Orion Minerals Limited · Mar 30, 2016
Entitlement Issue Prospectus
Orion Minerals Limited · Mar 30, 2016
Orica to demerge DuluxGroup
Orica Limited · Mar 30, 2016
Federal Court Judgment - Pharmaceuticals Case
Orica Limited · Mar 30, 2016
Environmental Provisions and Pharmaceuticals Tax Case Update
Orica Limited · Mar 30, 2016
Pharmaceuticals Tax Case Settled
Orica Limited · Mar 30, 2016
Kooragang Island Ammonium Nitrate Plant Expansion
Orica Limited · Mar 30, 2016
DuluxGroup Demerger Information Pack
Orica Limited · Mar 30, 2016
Managing Director and CEO Comments
Orica Limited · Mar 30, 2016
Orica Receives Prevention Notice from OEH
Orica Limited · Mar 30, 2016
Orica announces new CEO to assume role in 2012
Orica Limited · Mar 30, 2016
NSW EPA Lifts Prevention Notice on Ammonia Storage at KI
Orica Limited · Mar 30, 2016
EPA Lifts Prevention Notice on Ammonia Plant at KI Site
Orica Limited · Mar 30, 2016